Brooke Sutherland, Columnist

No Takeover Premium, No Problem

Combining with AmSurg could mean a payoff for shareholders down the road.

June 16, 2016 at 2:58 PM UTC

Brooke Sutherland is Bloomberg News' Boston bureau chief and writes the Industrial Strength Newsletter. She was previously a Bloomberg Opinion columnist covering deals and industrial companies and an M&A reporter for Bloomberg News.

Provide news feedback or report an error

Site feedback:

Take our Survey

This article is for subscribers only.

Oh sorry, did you want a premium with that?

When news broke last week about a possible merger of AmSurg and Envision Healthcare, investors were betting that the deal between the two big U.S. hospital-services providers would be arranged as a typical takeover, with at least some sort of stock price bump for Envision. That sent Envision's shares surging more than 8 percent to their highest levels of the year.